Department of Dermatology, University of Lübeck
Lübeck, Schleswig-Holstein, 23538, Germany
NCT Number: NCT02941432
Facial eczema and perioral dermatitis are clinical entities that develop exclusively in the face and present a special therapeutic challenge. Topical corticosteroids that are commonly applied to treat eczema/dermatitis at other body sites are best avoided in the face, as they may result in rapid atrophy of facial skin and in the long term rather aggravate facial dermatoses. Black tea compresses have been successfully used by German-speaking dermatologists to treat facial eczema/dermatitis for decades. The precise mechanism of action is unknown but is presumably based on astringent properties of tannins in the black tea and on the antiinflammatory action of a wet compress as such. This therapy is cheap, universally available and practically free of side-effects. Despite these perceived advantages the effects and tolerance of black tea compresses have not been formally studied to date. Therefore, the investigators plan to treat 25 patients with facial eczema/perioral dermatitis over a period of 6 days each within the current trial. The disease activity will be assessed before, during and after completion of treatment using several clinical scores. In addition, side-effects, if any, will be documented.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lübeck, Schleswig-Holstein, 23538, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wet compresses with black tea applied 4-5 times daily to the face for 6 days
Time frame: days 0, 3 and 6
Time frame: days 0, 3 and 6
Time frame: days 0, 3 and 6
Time frame: days 0, 3 and 6
Time frame: days 0, 3 and 6
Time frame: days 0, 3 and 6
Time frame: days 3 and 6
University of Luebeck
Other
Pilot Study of Effects and Tolerance of Black Tea Compress Treatment in Facial Eczema and Perioral Dermatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05990725
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Augsburg, Germany
View Trial DetailsNCT06585202
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial DetailsNCT06248814
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Prague, PR, Czechia
View Trial DetailsNCT04392154
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Anniston, Alabama, United States
View Trial Details